Add to Favourites
To login click here
The global AI in Drug Discovery market is expected to experience significant growth in the coming years, driven by the integration of AI in drug development processes. AI offers capabilities such as virtual screening and property optimization, which streamline workflows and reduce time and costs. However, challenges such as insufficient data sets and ethical concerns remain. Key players in the market include NVIDIA, Exscientia, BenevolentAI, and Google, who are actively developing innovative AI solutions for drug discovery and development.